• 1
    O'Grady MR, O'Sullivan ML. Dilated cardiomyopathy: An update. Vet Clin North Am Small Anim Pract 2004;34:11871207.
  • 2
    Tidholm A, Haggstrom J, Borgarelli M, et al. Canine idiopathic dilated cardiomyopathy. Part I: Aetiology, clinical characteristics, epidemiology and pathology. Vet J 2001;162:92107.
  • 3
    Vollmar AC. The prevalence of cardiomyopathy in the Irish wolfhound: A clinical study of 500 dogs. J Am Anim Hosp Assoc 2000;36:125132.
  • 4
    Calvert CA, Meurs K. Cardiomyopathy in Doberman Pinschers. In: BonaguraJD, TwedtDC, eds. Current Veterinary Therapy. St Louis, MO: Saunders Elsevier; 2009:800803.
  • 5
    Calvert CA, Brown J. Influence of antiarrhythmia therapy on survival times of 19 clinically healthy Doberman Pinschers with dilated cardiomyopathy that experienced syncope, ventricular tachycardia, and sudden death (1985–1998). J Am Anim Hosp Assoc 2004;40:2428.
  • 6
    Calvert CA, Chapman WL Jr, Toal RL. Congestive cardiomyopathy in Doberman Pinscher dogs. J Am Vet Med Assoc 1982;181:598602.
  • 7
    Calvert CA, Meurs K. CVT update: Doberman Pinscher occult cardiomyopathy. In: BonaguraJD, KirkRW, eds. Kirk's Current Veterinary Therapy. Philadelphia, PA: Saunders; 2000: 756760.
  • 8
    Calvert CA, Hall G, Jacobs G, et al. Clinical and pathologic findings in Doberman Pinschers with occult cardiomyopathy that died suddenly or developed congestive heart failure: 54 cases (1984–1991). J Am Vet Med Assoc 1997;210:505511.
  • 9
    Calvert CA, Pickus CW, Jacobs GJ, et al. Signalment, survival, and prognostic factors in Doberman Pinschers with end-stage cardiomyopathy. J Vet Intern Med 1997;11:323326.
  • 10
    Petric AD, Stabej P, Zemva A. Dilated cardiomyopathy in Doberman Pinschers: Survival, causes of death and a pedigree review in a related line. J Vet Cardiol 2002;4:1724.
  • 11
    Calvert CA, Jacobs G, Pickus CW, et al. Results of ambulatory electrocardiography in overtly healthy Doberman Pinschers with echocardiographic abnormalities. J Am Vet Med Assoc 2000;217:13281332.
  • 12
    Calvert CA, Jacobs GJ. Heart rate variability in Doberman Pinschers with and without echocardiographic evidence of dilated cardiomyopathy. Am J Vet Res 2000;61:506511.
  • 13
    Calvert CA, Jacobs GJ, Kraus M. Possible ventricular late potentials in Doberman Pinschers with occult cardiomyopathy. J Am Vet Med Assoc 1998;213:235239.
  • 14
    Calvert CA, Jacobs GJ, Kraus M, et al. Signal-averaged electrocardiograms in normal Doberman Pinschers. J Vet Intern Med 1998;12:355364.
  • 15
    Calvert CA, Jacobs GJ, Smith DD, et al. Association between results of ambulatory electrocardiography and development of cardiomyopathy during long-term follow-up of Doberman Pinschers. J Am Vet Med Assoc 2000;216:3439.
  • 16
    O'Grady MR, Home R. The prevalence of dilated cardiomyopathy in Doberman Pinschers: A 4.5 year follow-up. J Vet Intern Med 1998;12:199.
  • 17
    Hazlett MJ, Maxie MG, Allen DG, et al. A retrospective study of heart disease in Doberman Pinscher dogs. Can Vet J 1983;24:205210.
  • 18
    O'Grady MR, O'Sullivan ML, Minors SL, et al. Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers. J Vet Intern Med 2009;23:977983.
  • 19
    O'Grady MR, Minors SL, O'Sullivan ML, et al. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy. J Vet Intern Med 2008;22:897904.
  • 20
    Calvert CA, Brown J. Use of M-mode echocardiography in the diagnosis of congestive cardiomyopathy in Doberman Pinschers. J Am Vet Med Assoc 1986;189:293297.
  • 21
    Kraus MS, Thomason JD, Fallaw TL, et al. Toxicity in Doberman Pinchers with ventricular arrhythmias treated with amiodarone (1996–2005). J Vet Intern Med 2009;23:16.
  • 22
    O'Grady MR. DCM in Doberman Pinschers: Lessons learned in the first decade of study. Proceedings 20th annual ACVIM Forum, Denver, CO, 2002.
  • 23
    Quinones MA, Waggoner AD, Reduto LA, et al. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981;64:744753.
  • 24
    Teichholz LE, Kreulen T, Herman MV, et al. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976;37:711.
  • 25
    Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79108.
  • 26
    Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:14401463.
  • 27
    Malm S, Sagberg E, Larsson H, et al. Choosing apical long-axis instead of two-chamber view gives more accurate biplane echocardiographic measurements of left ventricular ejection fraction: A comparison with magnetic resonance imaging. J Am Soc Echocardiogr 2005;18:10441050.
  • 28
    Nosir YF, Vletter WB, Boersma E, et al. The apical long-axis rather than the two-chamber view should be used in combination with the four-chamber view for accurate assessment of left ventricular volumes and function. Eur Heart J 1997;18:11751185.
  • 29
    Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 1993;7:247252.
  • 30
    Kirk RW. Current veterinary therapy. Small Anim Pract 2000;XIII:800803.
  • 31
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307310.
  • 32
    Serres F, Chetboul V, Tissier R, et al. Comparison of 3 ultrasound methods for quantifying left ventricular systolic function: Correlation with disease severity and prognostic value in dogs with mitral valve disease. J Vet Intern Med 2008;22:566577.
  • 33
    Takemoto Y, Tanabe K, Chandrasekaran K, et al. Single-plane and biplane echocardiography: Use of targeted scan planes improves the estimates of left ventricular volume and shape for analysis of postinfarction remodeling. J Am Soc Echocardiogr 2003;16:448456.
  • 34
    Serres F, Pouchelon JL, Poujol L, et al. Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission. J Vet Cardiol 2009;11:103121.
  • 35
    Dukes-McEwan J. Comparison between right and left cardiac windows to determine left ventricular volumes and ejection fraction in six dog breeds with differing somatotypes. Eur J Ultrasound 2002;27:S4S5.
  • 36
    O'Sullivan ML, O'Grady MR, Minors SL. Assessment of diastolic function by Doppler echocardiography in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy. J Vet Intern Med 2007;21:8191.
  • 37
    Dukes-McEwan J, Borgarelli M, Tidholm A, et al. Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. J Vet Cardiol 2003;5:719.
  • 38
    Smucker ML, Kaul S, Woodfield JA, et al. Naturally occurring cardiomyopathy in the Doberman Pinscher: A possible large animal model of human cardiomyopathy? J Am Coll Cardiol 1990;16:200206.